Division of Gastroenterology & Liver Diseases

Dr. Dana J. Lukin, M.D.,  Ph.D.

Dana J. Lukin, M.D., Ph.D.

Assistant Professor, Department of Medicine (Gastroenterology & Liver Diseases)

Areas of Research: Inflammatory Bowel Disease Clinical Trials Crohn's Disease Ulcerative Colitis Intestinal Permeability

Professional Interests

Dr. Dana Lukin specializes in the care of patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. He completed medical and graduate training as well as residency in internal medicine at Mount Sinai School of Medicine, followed by fellowship training in gastroenterology at Columbia University Medical Center.

Dr. Lukin works closely with colleagues in affiliated specialties in order to provide comprehensive care for IBD patients as the Director of the Einstein-Montefiore Program for Inflammatory Bowel Diseases. He serves on the Chapter Medical Advisory Committee (CMAC) for the New York Chapter of the Crohn’s and Colitis Foundation of America (CCFA) as well as the CCFA Fellow’s Committee. He is a founding member of IBD-REMEDY (REsearch Mentoring EDucation new York) and serves on the Executive Committee of the New York Crohn’s and Colitis Organization (NYCCO). 

With interests in clinical and translational research in IBD, Dr. Lukin is participating in several phase II and phase III Crohn’s disease and ulcerative colitis trials. His current translational research focuses on the microbiome in IBD as well as the role of indoles in intestinal permeability and signaling through the pregnane X receptor (PXR) and TLR4, funded by a pilot grant from the CCFA-Broad Medical Research Program.  

Selected Publications

Dulai PS, Singh S, Jiang X, Perrani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF.  The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results from the US VICTORY Consortium.  Am J Gastroenterol. 2016 Aug; 111(8): 1147-55. doi: 10.1038/ajg.2016.236. Epub 2016 Jun 14. 

Brave M, Lukin D, and Mani S.  Microbial Control of Intestinal Innate Immunity. Oncotarget. 2015 [Epub ahead of print] PMID 26172839

 Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, Mceachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S.  Risk of New or Recurrent Cancer in Patients with Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-TNF Agents.   Clin Gastroenterol Hepatol. 2015 Aug 3. [Epub ahead of print]. Pii: S1542-3565 (15)01052-6.  PMID 26247164

Lukin DJ, Carvajal LA, Liu WJ, Resnick-Silverman L, Manfredi JJ.  p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints. Mol Cancer Res. 2015 Jan;13(1):16-28. doi: 10.1158/1541-7786.MCR-14-0177. Epub 2014 Aug 26. PMID: 25158956

Lukin DJ and Swaminath AC.  Case Report: Laryngeal Retention of a Video Capsule. Vis. Hum. J. Endoscopy. Volume 13, No. 1 (2014)

Westphalen CB, Asfaha S, Hayakawa Y, Takemoto Y, Lukin DJ, Nuber AH, Brandtner A, Setlik W, Remotti H, Muley A, Chen X, May R, Houchen CW, Fox JG, Gershon MD, Quante M, Wang TC.  Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest. 2014 Mar;124(3):1283-95. PMID: 24487592

Hamard PJ, Lukin DJ, Manfredi JJ.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.  J Biol Chem. 2012 Jun 22;287(26):22397-407. doi: 10.1074/jbc.M111.331298. Epub 2012 Apr 18. PMID: 22514277

Lukin DJ, Jandorf LH, Dhulkifl RJ, Thélémaque LD, Christie JA, Itzkowitz SH, Duhamel KN. Effect of comorbid conditions on adherence to colorectal cancer screening.  J Cancer Educ. 2012 Jun;27(2):269-76. doi: 10.1007/s13187-011-0303-2. PMID: 22351374

More Information About Dr. Dana Lukin

Montefiore Medical Center Profile

Einstein-Montefiore Program for Inflammatory Bowel Diseases

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467

Tel: 347.671.8207
Fax: 718.798.6408

Research Information

Click here to log in